Skip to main content

Table 4 PCR-corrected treatment responses in the ITT population on D28.

From: Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria

Outcome

ASAQ1

(N = 310)

ASAQ2

(N = 315)

AL

(N = 311)

Total

5

Possible failure (information unavailable)

12

(3.9%)

16

(5.1%)

9

(2.9%)

37

(4.0%)

Late clinical failure

None

None

2

(0.6%)

2

(0.2%)

Late parasitological failure

3

(1.0%)

None

3

(1.0%)

6

(0.6%)

Adequate clinical and parasitological response

295

(95.2%)

299

(94.9%)

297

(95.5%)

891

(95.2%)